DERM
Journey Medical Stock Analysis
AI Rating
- Quality1/10
- Growth↓ 1/10
- Value↓ 1/10
DERM Growth
- Revenue Y/Y↓ -2.78%
- EPS Y/Y↑ 5.13%
- FCF Y/Y↓ 3.46%
DERM Profitability
- Gross margin ↑ 65.40%
- EPS margin↓ -14.80%
- ROIC 5Y↓ 40.42%
DERM Risk
- Debt / Equity↓ 0.8
- Debt / FCF↓ 0.0
- Interest coverage↓ -1.6
Journey Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.